🇺🇸 FDA

Company profile · Sponsor

Serina

Serina Therapeutics

SER · NYSE pharma HUNTSVILLE, AL, USA
Pipeline
2
Drugs
0
Patents
8

Quick answer

Serina (SER) is a pharma company. headquartered in HUNTSVILLE, AL, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker SER
Exchange NYSE
Company type pharma
Headquarters HUNTSVILLE, AL, USA
SEC CIK 0001708599

Pipeline (2)

Search pipeline →

  1. SER-214

    Serina

    Parkinson's Disease

    phase 1 small molecule active

    1 trial

  2. SER-252 (PEOZ-apomorphine)

    Serina

    PARKINSON DISEASE (Disorder)

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12383625

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12383626

    Polyoxazoline-drug conjugates with novel pharmacokinetic properties

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12233132

    Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11944618

    Subcutaneous delivery of polymer conjugates of therapeutic agents

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11925689

    Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11766432

    Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same

    Expires Mon Sep 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11298350

    Subcutaneous delivery of polymer conjugates of therapeutics agents

    Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11224595

    Subcutaneous delivery of poly(oxazoline) polymer conjugates

    Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Serina?

Serina (SER) is a pharma company. headquartered in HUNTSVILLE, AL, USA. listed on NYSE. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does Serina sponsor?

We track 2 ClinicalTrials.gov-linked programs for Serina, including SER-214 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Serina company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.